骨髓间充质干细胞移植在肝再生中的应用

熊云川; 高宏; 李敏

骨髓间充质干细胞移植在肝再生中的应用

1. 重庆市第六人民医院外一科
2. 重庆医科大学附属第二医院肝胆外科

详细信息

中图分类号: R657.31
计量
- 文章访问数: 3834
- HTML全文浏览量: 17
- PDF下载量: 639
- 被引次数: 0
出版历程
- 出版日期: 2011-09-20

The application of bone marrow mesenchymal stem cells transplantation in liver regeneration

摘要

摘要: 随着当今医学的发展,干细胞的应用逐渐涉及到各个领域,并发挥着无限的潜能。干细胞以其自我更新及多向分化的能力可以对多种疾病进行替代治疗。肝病终末期肝细胞数量减少,肝功能衰竭,通过干细胞的替代治疗,肝功能能够得以改善,肝纤维化得到缓解甚至逆转。干细胞治疗成为有望替代肝移植的新技术。此文就干细胞在肝病治疗中的潜能作一综述,包括干细胞的来源、治疗机制、治疗途径,并对其临床应用进行探讨。
- 干细胞移植 /
- 骨髓细胞 /
- 间质干细胞 /
- 肝再生
Abstract: With the development of modern medicine, stem cells with unlimited potential was gradually involved in various fields.The ability of self-renewal and multidirectional differentiation can offer replacement treatment for multiple diseases.In the end-stage of liver disease, with the reduction of liver cells and failure of liver function, liver function can be improved and liver fibrosis can be slowed or even reversed through the replacement therapy of stem cell.Stem cell therapy is expected to be the new technology for the replacement of liver transplantation.This review summarizes the general understanding of the therapeutic potentials of stem cells in liver disease, including the sources, mechanisms, and threapy methods of hepatic stem cells, and discusses some challenges for their therapeutic application.
- stem cell transplantation /
- bone marrow cells /
- mesenchymal stem cells /
- liver regeneration

HTML全文

参考文献(20)

[1]Kisseleva T, Gigante E, Brenner DA.Recent advances in liv-er stem cell therapy[J].Curr Opin Gastroenterol, 2010, 26 (4) :395-402.

[2]BasmaH, Soto-Gutierrez A, Yannam GR, et al.Differentia-tion and transplantation of human embryonic stem cell-de-rived hepatocytes[J].Gastroenterology, 2009, 136:990-999.

[3] Gilchrist ES, Plevris JN. Bone marrow-derived stem cells in liver repair: 10 years down the line[J]. Liver Transpl, 2010, 16 (2) : 118-129.

[4]Tajima F, Tsuchiya H, Nishikawa K, et al.Hepatocyte growthfactor mobilizes and recruits hematopoietic progenitor cells intoliver through astem cellfactor-mediatedmechanism[J].Hep-atol Res, 2010, 40 (7) :711-719.

[5]Aurich H, SgoddaM, Kaltwasser P, et al.Hepatocyte differ-entiation of mesenchymal stem cells from human adipose tis-sue in vitro promotes hepatic integration in vivo[J].Gut, 2009, 58 (4) :570-581.

[6]Yagi H, Parekkadan B, Suganuma K, et al.Long-term su-perior performance of a stem cell/hepatocyte device for thetreatment of acute liver failure[J].Tissue Eng Part A, 2009, 15 (11) :3377-3388.

[7]Banas A, Teratani T, Yamamoto Y, et al.Rapid hepatic fatespecification of adipose-derived stem cells and their thera-peutic potential for liver failure[J].J Gastroenterol Hepatol, 2009, 24 (1) :70-77.

[8]Kharaziha P, Hellstrim PM, Noorinayer B, et al.Improve-ment of liver function in liver cirrhosis patients after autolo-gous mesenchymal stem cell injection:a phase I-II clinicaltrial[J].Eur J Gastroenterol Hepatol, 2009, 21 (10) :1199-1205.

[9] Ramasamy R, Lam EW, Soeiro I, et al. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth[J]. Leukemia, 2007, 21 (2) : 3040-310.

[10]Alberti E, Los M, GarciaR, et al.Prolonged survival and ex-pression of neural markers by bone marrow derived stemcells transplanted into brain lesions[J].Med Sci Munit, 2009, 15 (2) :BR47-54.

[11]Hu J, Feng K, Liu X, et al.Chondrogenic and osteogenicdifferentiations of human bone marrow-derived mesenchy-ma1 stem cells on ananofibrous scaffold with designed porenetwork[J].Biomaterials, 2009, 30 (28) :5061-5067.

[12]Chivu M, Dima SO, Stancu CI, et al.In vitro hepatic differ-entiation of human bone marrow mesenchymal stem cellsunder differential exposure to liver specific factors[J].TranslRes, 2009, 154 (3) :122-132.

[13]Bonora-Centelles A, Jover R, Mirabet V, et al.Sequentialhepatogenic trans-diferentiation of adipose tissue-derivedstem cells:relevance of different extracellular signaling mole-cules, transcription factors involved and expression of newkey marker genes[J].Cell Transplant, 2009, 18 (12) :1319-1340.

[14] Quintana-Bustamante O, Alvarez-Barrientos A, Kofman AV, et al. Hematopoietic mobilization in mice increases the presence of bone marrow-derived hepatocytes via in vivo cell fusion[J]. Hepatology, 2006, 43 (1) : 108-116.

[15]Sato Y, Araki H, Kato J, et al.Human mesenchymal stemcells xenografted directly to rat liver are differentiated into hu-man hepatocytes without fusion[J].Blood, 2005, 106 (2) :756-763.

[16]Van Poll D, Parekkadan B, Cho CH, et al.Mesenchymalstem cell-derived molecules directly modulate hepatocellu-lar death and regeneration in vitro and in vivo[J].Hepatolo-gy, 2008, 47 (5) :1634-1643.

[17] Kuo TK, Hung SP, Chuang CH, et al. Stem cell therapy in liver disease: parameters governing the success of using bone marrow mesenchymal stem cells[J]. Gastrenterology , 2008, 134 (7) : 2111-2121.

[18] Kim WH, Matsumoto K, Bessho K, et al. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis[J]. Am J Pathol, 2005, 166 (7) : 1017-1028.

[19]Carvalho AB, Quintanilha LF, Dias JV, et al.Bone marrowmultipotent mesenchymal stromal cells do not reduce fibrosisor improve function in arat model of severe chronic liver inju-ry[J].Stem Cells, 2008, 26:1307-1314.

[20]Chen Z, Qi LZ, Zeng R, et al.Stem cells and hepatic cirrho-sis[J].Panminerva Med, 2010, 52 (2) :149-165.

施引文献

资源附件(0)

访问统计